[Articles] Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Journal content Created on 11 Sep 2026 The Lancet

• Details
• • All feed content
  • My feed content